White matter (WM) degeneration is a critical component of early Alzheimer’s disease (AD) pathophysiology.
The Waisman Center’s signature research project looks deeply at the connections between autism and ADHD
Josh loves coming to the Waisman Center. He has told his mom Julia several times that he particularly enjoys the two-day visits because he gets to spend more time at the center. His brain is special so it is cool that the scientists want to study it, he tells Julia.
Nancy Saevang recognized among Wisconsin’s Most Influential Asian American Leaders for 2023
Nancy is director of the Waisman Early Childhood Program at the University of Wisconsin-Madison, leading a staff of 17 caring for about 100 children aged 12 months to eight years.
Artificial intelligence: A real tool for advancing research on intellectual and developmental disabilities and beyond
AI collects big data and uses computer algorithms to search patterns that are present in your daily life.
Carlos Benítez-Barrera, PhD – Slide of the Week
Cultural differences in environmental auditory ecology are usually studied using geographic area monitoring.
New research expands understanding of impact of rapamycin on fragile X syndrome
Fragile X syndrome (FXS) is the most common heritable form of intellectual and developmental disability. It is also the most common single genetic contributor to autism spectrum disorder (ASD).
The large scope of research on fragile X syndrome at the Waisman Center
Research studies at the Waisman Center cover both basic science and behavioral research on FXS, starting with the individual, up to the family unit, from childhood, and into old age.
Research beyond Waisman Center: Discoveries that have spun into products
Multiple discoveries born from the minds and hard work of Waisman Center investigators have left the nest to become successful companies or products that have had a significant impact in the world through translational research.
Xinyu Zhao, PhD – Slide of the Week
Fragile X messenger ribonucleoprotein 1 protein (FMRP) binds many mRNA targets in the brain. The contribution of these targets to fragile X syndrome (FXS) and related autism spectrum disorder (ASD) remain unclear.
Waisman and PKU: A legacy of being at the forefront of research and care
In 1972, Nancy Reyzer had only been home in Chicago a couple of days with her newborn son, John, when she received an unexpected and alarming phone call from her son’s doctor. The doctor said that her son may have a condition called phenylketonuria and that they needed to come into the clinic immediately.